True North Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
True North Advisors's IDXX Position: Q2 2026 in Review
True North Advisors reduced its Idexx Laboratories (IDXX) stake by 2.1% in Q2 2026, selling an estimated $16.3K and leaving 1,382 shares worth $728K. The position accounts for 0.07% of the portfolio, ranked #143.
True North Advisors first reported a position in IDXX in Q1 2026 and has held it in 2 quarters since. The position peaked at $793K in Q1 2026. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- True North Advisors held 1,382 shares of Idexx Laboratories worth $728K as of Q2 2026.
- True North Advisors sold 29 Idexx Laboratories shares in Q2 2026, an estimated $16.3K.
- Idexx Laboratories made up 0.07% of True North Advisors's portfolio in Q2 2026, its #143 holding.
- True North Advisors first reported a position in Idexx Laboratories in Q1 2026 and has held it in 2 quarters since.
- True North Advisors's Idexx Laboratories position peaked at $793K in Q1 2026.
- 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on True North Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.